THOMAS KOSTEN to Vaccines
This is a "connection" page, showing publications THOMAS KOSTEN has written about Vaccines.
Connection Strength
6.581
-
Vaccines as Immunotherapies for Substance Use Disorders. Am J Psychiatry. 2024 May 01; 181(5):362-371.
Score: 0.614
-
Current status of vaccines for substance use disorders: A brief review of human studies. J Neurol Sci. 2022 Mar 15; 434:120098.
Score: 0.521
-
The Hidden Epidemic of Opioid Overdoses During the Coronavirus Disease 2019 Pandemic. JAMA Psychiatry. 2021 06 01; 78(6):585-586.
Score: 0.501
-
Psychopharmacology: neuroimmune signaling in psychiatric disease-developing vaccines against abused drugs using toll-like receptor agonists. Psychopharmacology (Berl). 2019 Oct; 236(10):2899-2907.
Score: 0.427
-
Current status and future prospects for the development of substance abuse vaccines. Expert Rev Vaccines. 2017 11; 16(11):1067-1077.
Score: 0.388
-
The future potential for cocaine vaccines. Expert Opin Biol Ther. 2014 Sep; 14(9):1271-83.
Score: 0.308
-
Vaccine for cocaine dependence: a randomized double-blind placebo-controlled efficacy trial. Drug Alcohol Depend. 2014 Jul 01; 140:42-7.
Score: 0.306
-
Vaccines against stimulants: cocaine and MA. Br J Clin Pharmacol. 2014 Feb; 77(2):368-74.
Score: 0.302
-
The ?-opioid receptor gene as a predictor of response in a cocaine vaccine clinical trial. Psychiatr Genet. 2013 Dec; 23(6):225-32.
Score: 0.298
-
Can you vaccinate against substance abuse? Expert Opin Biol Ther. 2013 Aug; 13(8):1093-7.
Score: 0.286
-
Prospects, promise and problems on the road to effective vaccines and related therapies for substance abuse. Expert Rev Vaccines. 2013 Mar; 12(3):323-32.
Score: 0.283
-
DBH gene as predictor of response in a cocaine vaccine clinical trial. Neurosci Lett. 2013 Apr 29; 541:29-33.
Score: 0.283
-
Immunotherapy for drug abuse. CNS Neurol Disord Drug Targets. 2011 Dec; 10(8):876-9.
Score: 0.259
-
Vaccines against drug abuse. Clin Pharmacol Ther. 2012 Jan; 91(1):60-70.
Score: 0.259
-
Substance abuse vaccines. Ann N Y Acad Sci. 2008 Oct; 1141:257-69.
Score: 0.208
-
The future of vaccines in the management of addictive disorders. Curr Psychiatry Rep. 2007 Oct; 9(5):381-7.
Score: 0.194
-
Vaccine pharmacotherapy for the treatment of cocaine dependence. Biol Psychiatry. 2005 Jul 15; 58(2):158-64.
Score: 0.167
-
Future of anti-addiction vaccines. Stud Health Technol Inform. 2005; 118:177-85.
Score: 0.161
-
Therapeutic vaccines for substance dependence. Expert Rev Vaccines. 2004 Feb; 3(1):11-8.
Score: 0.151
-
Therapeutic vaccines for substance dependence. Expert Rev Vaccines. 2002 Oct; 1(3):363-71.
Score: 0.137
-
Human therapeutic cocaine vaccine: safety and immunogenicity. Vaccine. 2002 Jan 15; 20(7-8):1196-204.
Score: 0.131
-
Attenuation of cocaine-induced locomotor activity in male and female mice by active immunization. Am J Addict. 2014 Nov-Dec; 23(6):604-7.
Score: 0.079
-
A vaccine against methamphetamine attenuates its behavioral effects in mice. Drug Alcohol Depend. 2013 Apr 01; 129(1-2):41-8.
Score: 0.069
-
Effects of anti-cocaine vaccine and viral gene transfer of cocaine hydrolase in mice on cocaine toxicity including motor strength and liver damage. Chem Biol Interact. 2013 Mar 25; 203(1):208-11.
Score: 0.068
-
Anti-cocaine vaccine development. Expert Rev Vaccines. 2010 Sep; 9(9):1109-14.
Score: 0.059
-
Emerging pharmacological strategies in the fight against cocaine addiction. Expert Opin Emerg Drugs. 2006 Mar; 11(1):91-8.
Score: 0.044
-
Immunotherapy for the treatment of drug abuse. Pharmacol Ther. 2005 Oct; 108(1):76-85.
Score: 0.042
-
Hapten optimization for cocaine vaccine with improved cocaine recognition. Chem Biol Drug Des. 2014 Sep; 84(3):354-63.
Score: 0.020
-
Anti-cocaine antibody and butyrylcholinesterase-derived cocaine hydrolase exert cooperative effects on cocaine pharmacokinetics and cocaine-induced locomotor activity in mice. Chem Biol Interact. 2013 Mar 25; 203(1):212-6.
Score: 0.017